Here’s how to play what should have been the hottest IPO of the year…

Sometimes you can do everything right and no one appreciates it.

Like this one tiny cannabis company that you’ve probably never heard of – even though you should have.

It’s based in Massachusetts and owns coveted cannabis licenses in some of the most valuable markets in the country, including one of only 12 in New York.

New York is still a medical-only market right now with sales projected to reach $80 million in 2021, according to Marijuana Business Factbook.

Not all that impressive… But here’s where the big profit potential comes into play.

New York voters said “Yes” to recreational legalization in 2020. And by 2027, with recreational sales kicking off once a framework is in place, legal cannabis sales are expected to reach $5.8 billion.

The fact that this company owns one of only 12 current licenses in the state gives it a massive first-mover advantage.

And that’s just another cherry on top of what this company already has going for it, with additional operations in Illinois, Michigan, New Jersey, Massachusetts, and Ohio.

It’s been able to increase its revenue by 12X from 2019 to 2020, and just halfway through 2021, revenues have already surpassed what it brought in for all of 2020.

That puts it on track to generate $344 million in revenue this year – and it could nearly double that to $630 million in 2022.

With all of these successes, this company should have been considered the hottest IPO of the year when it went public in May.

The toast of the town.

It wasn’t. But fortunately, this company being underappreciated right now works out for you…

Because as of this writing, shares are trading for just over $9.

It’s only a matter of time before this company gets the attention it deserves.

Analysts will bang the table and tell the masses to buy, and you’ll see it appear on those lists of the best cannabis stocks to buy once everyone realizes the golden opportunity they’ve been overlooking.

I want to make sure that you’re one step ahead of everyone else.

Which is why we’ll be recommending this company to our NICI Membership subscribers on October 1st with a special dossier outlining the full opportunity.

If you’re a member, you don’t have to lift a finger. The trade will hit your inbox directly.

But before then, I wanted to give you a sneak peek…

Again, if you are already a member, you don’t have to do a thing but open your email on Friday!

If you’re not a member, to make sure you get Friday’s trade delivered straight to your inbox, simply click here right now.

Editor’s Note: Current NICI Membership subscribers can now access their trade recommendation and comprehensive dossier on this under-the-radar pot stock right here.

To your investing success,

Danny Brody
Executive Director, National Institute for Cannabis Investors


Leave a Reply

Your email address will not be published. Required fields are marked *